TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cutia Therapeutics ( (HK:2487) ) has provided an update.
Cutia Therapeutics announced the placement of 28,904,000 new shares under a general mandate, representing approximately 9.05% of its issued shares. The shares are priced at HK$8.40 each, generating estimated net proceeds of HK$240.26 million. This strategic move is expected to enhance the company’s financial position and support its ongoing growth in the dermatology sector.
The most recent analyst rating on (HK:2487) stock is a Hold with a HK$9.00 price target. To see the full list of analyst forecasts on Cutia Therapeutics stock, see the HK:2487 Stock Forecast page.
More about Cutia Therapeutics
Cutia Therapeutics is an investment holding company focused on developing innovative and comprehensive solutions for the dermatology treatment and care market.
Average Trading Volume: 1,252,347
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$3.14B
Find detailed analytics on 2487 stock on TipRanks’ Stock Analysis page.